Health & Beauty News

Pfizer Agrees To Buy Seagen For $43 Bn

Pfizer has agreed to pay USD 43 billion for biotech Seagen and its pioneering class of targeted cancer drugs, The Wall Street Journal reported. Under the terms, Pfizer would pay USD 229 a share in cash, the drugmaker said on Monday. The companies expect the deal, which includes debt, to close late this year or […]

Read More